Jupiter Life Line Hospitals Limited — Q2 FY26 earnings call

Call held 10 Nov 2025

Management summary

Jupiter Life Line Hospitals reported a solid Q2 and H1 FY26, with operating income growing 11.7% and 14.9% year-on-year respectively. EBITDA margins remained healthy at 22.8% for Q2 and 22.5% for H1. The company is on track with its expansion plans, with the Dombivali Hospital expected to commence operations in Q1 FY27 and construction for South Pune Hospital initiated. However, a one-time provision in professional fees and anticipated initial margin dilution from new hospitals were noted.

Highlights

  • Q2 FY26 Operating Income grew 11.7% YoY to ₹374.4 crores.

  • H1 FY26 Operating Income grew 14.9% YoY to ₹727.4 crores.

  • Dombivali Hospital is nearing completion and set to begin operations on schedule in Q1 FY27.

  • ARPOB for H1 FY26 improved to ₹66,100, an increase of ~15% from ₹57,700.

  • Company maintains strong liquidity with over ₹500 crores in liquid investments against ₹325 crores debt.

Concerns

  • Q2 FY26 EBITDA growth (9.3% YoY) was lower than Operating Income growth (11.7% YoY).

  • H1 FY26 PAT growth was only 5.3% YoY, significantly lower than revenue and EBITDA growth.

  • Temporary moderation of consolidated EBITDA margin expected when new hospitals like Dombivali become operational due to initial negative EBITDA.

  • One-time provision of ₹12 crores in professional fees due to new accounting treatment for unbilled revenue.

Key financials

3 periods

Headline

  • One-time Professional Fees Provision
    ₹12 Cr

Q2

  • Operating Income
    ₹374.4 Cr
    YoY +11.7%
  • EBITDA
    ₹85.4 Cr
    YoY +9.3%
  • EBITDA Margin
    22.8%
  • PAT
    ₹57.4 Cr
    YoY +11%
  • Occupancy Rate
    64.5%
  • Unbilled Revenue
    ₹19.2 Cr

H1

  • Operating Income
    ₹727.4 Cr
    YoY +14.9%
  • EBITDA
    ₹163.8 Cr
    YoY +13.7%
  • EBITDA Margin
    22.5%
  • PAT
    ₹101.4 Cr
    YoY +5.3%
  • ARPOB
    ₹66,100
  • ALOS
    3.84 days
  • Average Occupancy Rate
    62.2%

What they filed

Q1 FY27: revenue up 16.4%, net profit down 13.6% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue335 333 337 353 394 +18%365 +10%388 +15%411 +16%
EBITDA78 76 80 78 92 +18%83 +9%89 +11%79 +1%
Net profit52 52 45 44 57 +10%42 −19%50 +11%38 −14%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Capital allocation

high confidence
  • Capex Capex disclosed internal resources and future internal accruals
    • New project (Dombivali, South Pune, Mira Road) ₹110 Cr
    On the CAPEX side, this year so far, we have spent about Rs. 110 odd crores of CAPEX for the new project. ... we expect that we should probably be able to complete with our resources and future internal accrual.
  • Debt Gross ₹325 Cr Cost 7.5%
    The current consolidated debt stands at Rs. 325 crores. ... So, it is between 7% and 8%, I think, currently. But the carrying cost is pretty much around 1% because, as I said, we are holding.
  • Liquidity Cash ₹550 Cr Liquid investments and deposits of over Rs. 500 crores, around Rs. 550 crores at the end of September.
    Against that, we have liquid investments and deposits of over Rs. 500 crores, around Rs. 550 crores if I am not wrong at the end of September.

Guidance & targets

Capacity

  • Dombivali Hospital start of operations Capacity · Q1 FY27 · High confidence Q1 of the next financial year
    The Dombivali Hospital, as I said, is on track. It is forecasted to start in Q1 of the next financial year.

    — Dr. Ankit Thakker

  • Occupancy rate for considering expansion Capacity · Ongoing · High confidence Cross 60% of installed base
    But once, our general philosophy is that once we cross 60% occupancy of the installed base, we think about expansion.

    — Dr. Ankit Thakker

Profitability

  • New hospitals EBITDA margin Profitability · First year, second year of operation · High confidence EBITDA negative in the first year, break even in the second year
    As the new hospitals come up, they are expected to be EBITDA negative in the first year and break even in the second year.

    — Dr. Ankit Thakker

  • ARPOB in Dombivali Profitability · Early years of operation · High confidence Slightly lower than matured hospitals
    But because of early years, we should definitely expect a slightly lower ARPOB in Dombivali than we see in matured hospitals.

    — Dr. Ankit Thakker

  • Occupancy rate for break-even in new hospitals Profitability · Year two · Medium confidence Upwards of 40%, 45%
    Yes, so year two, I think we definitely think that a bit of break-even should happen. And that happens upwards of 40%, 45% occupancy, as we have seen.

    — Dr. Ankit Thakker

What to watch in Q3 FY26

Dombivali Hospital operationalization

Q1 FY27
Current Nearing completion
Target Operations commenced

Why it matters

Key growth driver, will add new bed capacity and revenue stream.

Our Dombivali Hospital is nearing completion and is set to begin operations on schedule without any foreseeable delay.

Risks & concerns

  • Initial margin dilution from new hospitals

    medium

    New hospitals are expected to be EBITDA negative in the first year, leading to consolidated margin dilution.

    Management acknowledged

  • Impact of new accounting treatment for unbilled revenue

    low

    Rs. 19.2 crores of unbilled revenue recognized in Q2, with a Rs. 12 crore one-time provision; expected to cancel out in future quarters.

    Analyst acknowledged

Q&A highlights

7 direct
CAPEX incurred and Dombivali Hospital status/hiring. Direct
The Dombivali Hospital, as I said, is on track. It is forecasted to start in Q1 of the next financial year... On the CAPEX side, this year so far, we have spent about Rs. 110 odd crores of CAPEX for the new project.

Provides concrete timelines for a key growth project and quantifies recent capital expenditure.

Asked by Mr. Rahul Jain

Medium-term EBITDA margin trajectory with Dombivali coming online. Direct
As the new hospitals come up, they are expected to be EBITDA negative in the first year and break even in the second year. So, as Dombivali comes up, it should lead to a little dilution in consolidated margin in the first year.

Addresses potential margin dilution from new projects, which is a common concern for hospital chains expanding.

Asked by Mr. Rahul Jain

Difference between reported revenue and presentation revenue (unbilled revenue). Direct
This period onwards, we have also started reporting this unbilled revenue. The revenue for this quarter is Rs. 19.2 crores... Next quarter onwards, they are broadly expected to cancel each other out... So, going forward from next quarter onwards, you should not see any significant impact of this.

Clarifies a change in accounting practice that impacted reported revenue for the quarter and explains its one-time nature.

Asked by Mr. Deven

Debt reduction strategy and cost of funding. Direct
The current consolidated debt stands at Rs. 325 crores. Against that, we have liquid investments and deposits of over Rs. 500 crores... So, it is between 7% and 8%, I think, currently. But the carrying cost is pretty much around 1% because, as I said, we are holding.

Provides details on debt levels, liquidity position, and effective cost of debt, indicating a strong financial position for expansion.

Asked by Mr. Amit

Inorganic growth plans and market expansion beyond Maharashtra. Direct
first inorganic, there is nothing live that we are chasing... On the focus areas, we are open to any sensible opportunity in Western India. We are open to Gujarat and Madhya Pradesh as well, not necessarily Maharashtra.

Outlines the company's strategic intent for future growth, indicating openness to new geographies in Western India.

Asked by Mr. Rishabh Sisodia

IP volumes decline in Q2 and its reasons. Direct
Q2 generally sees the occupancy peak due to infection burden... This year, Pune had a lower outbreak than usual... So, I am guessing that could be contributing to the Q2 numbers.

Explains a potential reason for lower occupancy/IP volumes in Q2, attributing it to lower seasonal infection outbreaks in Pune.

Asked by Mr. Dheeresh

Professional expenses growth and one-time provision. Direct
No, sir, this is completely one-off. ... There is a Rs. 12 crore one-time provision in the professional fee component based on this new policy, which we have done.

Clarifies that a significant increase in professional fees was a one-time accounting adjustment, not an ongoing operational cost increase.

Asked by Mr. Ankeet Pandya

Timeline for insurance tie-ups for new hospitals. Partial
I do not know. It is a dynamic process. So, I really cannot predict when it will start. But yes, we understand that cashless services are important for patients in today's time.

Highlights a practical challenge for new hospitals and management's commitment to addressing it, though without a specific timeline.

Asked by Mr. Rishabh Sisodia

2 min read 6 chapters

Detailed narrative

Q2 & H1 FY26 Financial Performance

Jupiter Life Line Hospitals reported a robust financial performance for Q2 and H1 FY26. The total operating income for Q2 stood at ₹374.4 crores, marking an 11.7% year-on-year increase, with EBITDA at ₹85.4 crores, growing 9.3% YoY and maintaining a 22.8% margin. For the first half of FY26, operating income reached ₹727.4 crores, up 14.9% YoY, and EBITDA was ₹163.8 crores, a 13.7% YoY increase, with a 22.5% margin. PAT for H1 FY26 grew 5.3% YoY to ₹101.4 crores.

Expansion Plans and Project Timelines

The company's expansion strategy is well on track. The Dombivali Hospital is nearing completion and is forecasted to commence operations in Q1 of the next financial year (FY27) without anticipated delays. Construction for the South Pune Hospital has begun in Q3 FY26, and the Mira Road Hospital is currently in the architectural drawing board phase. The company has spent approximately ₹110 crores on CAPEX for new projects in H1 FY26.

Occupancy and ARPOB Trends

For H1 FY26, the ARPOB stood at ₹66,100, and the average occupancy rate was 62.2% on expanded bed capacity. Q2 FY26 consolidated occupancy was 64.5%. Management noted that Thane hospitals are in the mid-70s occupancy, Pune is moving towards 70%, and Indore is showing increased occupancy and revenue. The Q2 occupancy in Pune was slightly lower than usual due to a reduced infection outbreak, which is a positive sign for community health.

Accounting Changes and One-time Items

Jupiter Life Line Hospitals has adopted a new accounting treatment for unbilled revenue, recognizing ₹19.2 crores in Q2 FY26. This change also led to a one-time provision of ₹12 crores in professional fees, comprising ₹3 crores for the unbilled revenue and ₹9.3 crores for unsettled/outstanding bills. Management expects this to be a one-time delta, with future quarters seeing these entries broadly cancel out.

Financial Strength and Debt Position

The company maintains a strong financial position with a consolidated debt of ₹325 crores, significantly offset by liquid investments and deposits exceeding ₹500 crores (around ₹550 crores as of September end). The blended cost of interest on the debt is between 7% and 8%, but the effective carrying cost is approximately 1% due to the substantial liquid assets. The company anticipates funding its ongoing three projects (Dombivali, South Pune, Mira Road) primarily through internal resources and future accruals.

Strategic Outlook and Payer Mix

The company's focus remains on expanding its presence in Western India by building high-quality hospital infrastructure. The payer mix for H1 FY26 remained stable, with insurance accounting for 55.5% of revenue, self-payers 43.2%, and government schemes 1.3%. Management is open to inorganic growth opportunities in Western India, including Gujarat and Madhya Pradesh, but currently has no live discussions.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Healthcare earnings calls